North America Viral Vector and Plasmid DNA Market is experiencing robust growth driven by the increasing development of gene therapies, cell-based therapies, and next-generation vaccines across the region. The strong presence of leading biotechnology and pharmaceutical companies, expanding clinical trial activities, and substantial investments in genomic research are accelerating the demand for...